These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9499597)

  • 21. Protein glycation in vivo: functional and structural effects on yeast enolase.
    Gomes RA; Oliveira LM; Silva M; Ascenso C; Quintas A; Costa G; Coelho AV; Sousa Silva M; Ferreira AE; Ponces Freire A; Cordeiro C
    Biochem J; 2008 Dec; 416(3):317-26. PubMed ID: 18651835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preferential recognition of Amadori-rich lysine residues by serum antibodies in diabetes mellitus: role of protein glycation in the disease process.
    Ansari NA; Moinuddin ; Alam K; Ali A
    Hum Immunol; 2009 Jun; 70(6):417-24. PubMed ID: 19332092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the amadori product in the complications of diabetes.
    Monnier VM; Sell DR; Dai Z; Nemet I; Collard F; Zhang J
    Ann N Y Acad Sci; 2008 Apr; 1126():81-8. PubMed ID: 18448799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cellular contraction of collagen lattices is inhibited by nonenzymatic glycation.
    Howard EW; Benton R; Ahern-Moore J; Tomasek JJ
    Exp Cell Res; 1996 Oct; 228(1):132-7. PubMed ID: 8892980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEing.
    Yan SF; Yan SD; Herold K; Ramsamy R; Schmidt AM
    Endocrinol Metab Clin North Am; 2006 Sep; 35(3):511-24, viii. PubMed ID: 16959583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental studies on the role of fructose in the development of diabetic complications.
    Sakai M; Oimomi M; Kasuga M
    Kobe J Med Sci; 2002 Dec; 48(5-6):125-36. PubMed ID: 12594356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization of the ezrin binding epitope for advanced glycation endproducts.
    McRobert EA; Tikoo A; Cooper ME; Bach LA
    Int J Biochem Cell Biol; 2008; 40(8):1570-80. PubMed ID: 18203644
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The contribution of glycation to cataract formation in diabetes.
    Stevens A
    J Am Optom Assoc; 1998 Aug; 69(8):519-30. PubMed ID: 9747048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative quantification of N(epsilon)-(Carboxymethyl)lysine, imidazolone A, and the Amadori product in glycated lysozyme by MALDI-TOF mass spectrometry.
    Kislinger T; Humeny A; Peich CC; Zhang X; Niwa T; Pischetsrieder M; Becker CM
    J Agric Food Chem; 2003 Jan; 51(1):51-7. PubMed ID: 12502384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The nonenzymatic glycation of proteins and nucleic acids, their importance for the development of diabetic complications, possible molecular basis of aging and autoimmunological processes.
    Krantz S; Lober M; Henschel L
    Exp Clin Endocrinol; 1986 Dec; 88(3):257-69. PubMed ID: 3549330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes.
    Lapolla A; Fedele D; Traldi P
    Mass Spectrom Rev; 2000; 19(5):279-304. PubMed ID: 11079246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes.
    Rojas A; Morales MA
    Life Sci; 2004 Dec; 76(7):715-30. PubMed ID: 15581904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced glycation endproducts: what is their relevance to diabetic complications?
    Ahmed N; Thornalley PJ
    Diabetes Obes Metab; 2007 May; 9(3):233-45. PubMed ID: 17391149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced glycation end products and sorbitol in blood from differently compensated diabetic dogs.
    Comazzi S; Bertazzolo W; Bonfanti U; Spagnolo V; Sartorelli P
    Res Vet Sci; 2008 Jun; 84(3):341-6. PubMed ID: 17631369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyperus rotundus suppresses AGE formation and protein oxidation in a model of fructose-mediated protein glycoxidation.
    Ardestani A; Yazdanparast R
    Int J Biol Macromol; 2007 Dec; 41(5):572-8. PubMed ID: 17765965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry.
    Miyazawa T; Ibusuki D; Yamashita S; Nakagawa K
    Ann N Y Acad Sci; 2008 Apr; 1126():291-4. PubMed ID: 18448834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Amadori product on protein: structure and reactions.
    Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
    Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of advanced glycated end-products.
    Gandhi JS; Patel V
    Postgrad Med J; 1999 Jul; 75(885):446-7. PubMed ID: 10474742
    [No Abstract]   [Full Text] [Related]  

  • 40. [Long-term complications in diabetes mellitus: role of irreversible glycosylation products].
    Treskes M; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1299-303. PubMed ID: 8710007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.